Soumit Roy

Stock Analyst at Jones Trading

(2.87)
# 1,726
Out of 5,042 analysts
43
Total ratings
31.25%
Success rate
5.29%
Average return

Stocks Rated by Soumit Roy

Anavex Life Sciences
Oct 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $8.62
Upside: -
CG Oncology
Sep 8, 2025
Initiates: Buy
Price Target: $50
Current: $43.67
Upside: +14.50%
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $5.10
Upside: +311.76%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $18.59
Upside: +115.17%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36$27
Current: $20.61
Upside: +31.00%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.07
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.20
Upside: -
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.09
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $7.07
Upside: +112.16%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $4.85
Upside: +106.19%
Upgrades: Buy
Price Target: $34
Current: $27.96
Upside: +21.60%
Upgrades: Buy
Price Target: $36
Current: $2.14
Upside: +1,582.24%
Initiates: Buy
Price Target: $32
Current: $3.32
Upside: +863.86%
Initiates: Buy
Price Target: $9
Current: $9.70
Upside: -7.22%
Initiates: Buy
Price Target: $17
Current: $13.10
Upside: +29.77%
Initiates: Buy
Price Target: $13
Current: $3.72
Upside: +249.46%
Maintains: Buy
Price Target: $6$4
Current: $0.89
Upside: +349.44%
Downgrades: Hold
Price Target: n/a
Current: $3.78
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $6.00
Upside: -
Maintains: Buy
Price Target: $22$26
Current: $7.76
Upside: +235.05%
Initiates: Buy
Price Target: $70
Current: $24.90
Upside: +181.12%
Upgrades: Buy
Price Target: $10
Current: $81.57
Upside: -87.74%
Downgrades: Hold
Price Target: n/a
Current: $5.76
Upside: -
Initiates: Buy
Price Target: $80
Current: $14.78
Upside: +441.27%
Downgrades: Hold
Price Target: n/a
Current: $1.54
Upside: -
Initiates: Buy
Price Target: $320
Current: $3.92
Upside: +8,063.27%
Initiates: Buy
Price Target: $810
Current: $6.72
Upside: +11,953.57%